Erythromycin C

Erythromycin C is a lipid of Polyketides (PK) class.

Cross Reference

There are no associated biomedical information in the current reference collection.

Current reference collection contains 35291 references associated with Erythromycin C in LipidPedia. Due to lack of full text of references or no associated biomedical terms are recognized in our current text-mining method, we cannot extract any biomedical terms related to diseases, pathways, locations, functions, genes, lipids, and animal models from the associated reference collection.

Users can download the reference list at the bottom of this page and read the reference manually to find out biomedical information.

All references with Erythromycin C

Download all related citations
Per page 10 20 50 100 | Total 7634
Authors Title Published Journal PubMed Link
Benedetti E et al. Treatment of severe pneumonia in kidney transplant recipients. 2001 Nov-Dec Transplant. Proc. pmid:11750552
Claesson K et al. Sirolimus and erythromycin interaction: two cases. 2001 Transplant. Proc. pmid:11377477
Ohmori M et al. Effect of erythromycin on ischemia-reperfusion injury of liver in rats. 2000 Transplant. Proc. pmid:10856595
Moreno M et al. Clinical management of tacrolimus drug interactions in renal transplant patients. 1999 Transplant. Proc. pmid:10500564
Moral A et al. Erythromycin ototoxicity in liver transplant patients. 1994 Transpl. Int. pmid:8117405
Mikura S et al. Erythromycin prevents the pulmonary inflammation induced by exposure to cigarette smoke. 2011 Transl Res pmid:21708354
Zhou Y et al. Erythromycin ameliorates cigarette-smoke-induced emphysema and inflammation in rats. 2012 Transl Res pmid:22633097
White A et al. Rapid diagnosis of Legionnaires' disease. 1982 Trans. Am. Clin. Climatol. Assoc. pmid:7048694
Nirankari VS et al. Antibiotic prophylaxis in corneal storage media. 1994 Trans Am Ophthalmol Soc pmid:7886863
Tsujimoto M et al. Effects of decreased vitamin D and accumulated uremic toxin on human CYP3A4 activity in patients with end-stage renal disease. 2013 Toxins (Basel) pmid:23965431
Roseghini M et al. Choline esters and biogenic amines in the hypobranchial gland of 55 molluscan species of the neogastropod Muricoidea superfamily. 1996 Toxicon pmid:8835333
Thibault N et al. Actin filament alteration as a potential marker for cholestasis: a study in isolated rat hepatocyte couplets. 1992 Toxicology pmid:1631904
Kilic B et al. The in vitro effects of quinupristin/dalfopristin, erythromycin and levofloxacin at low concentrations on the expression of different cell adhesion molecules on the surface of endothelial cells (Eahy926). 2006 Toxicology pmid:16297520
Rodrigues AD et al. Induction of the rat hepatic microsomal mixed-function oxidases by 3 imidazole-containing antifungal agents: selectivity for the cytochrome P-450IIB and P-450III families of cytochromes P-450. 1988 Toxicology pmid:3394156
Liu X et al. Potentials and mechanisms of genotoxicity of six pharmaceuticals frequently detected in freshwater environment. 2012 Toxicol. Lett. pmid:22450446
Sorensen EM and Acosta D Erythromycin estolate-induced toxicity in cultured rat hepatocytes. 1985 Toxicol. Lett. pmid:4060187
Saxena RP et al. Coir fibre toxicity: in vivo and in vitro studies. 1982 Toxicol. Lett. pmid:6283694
Montenez JP et al. Interactions of macrolide antibiotics (Erythromycin A, roxithromycin, erythromycylamine [Dirithromycin], and azithromycin) with phospholipids: computer-aided conformational analysis and studies on acellular and cell culture models. 1999 Toxicol. Appl. Pharmacol. pmid:10198278
Mahgoub A et al. Azithromycin and erythromycin ameliorate the extent of colonic damage induced by acetic acid in rats. 2005 Toxicol. Appl. Pharmacol. pmid:15885263
Gant TW et al. In vivo induction of liver P-glycoprotein expression by xenobiotics in monkeys. 1995 Toxicol. Appl. Pharmacol. pmid:7645023
Fujii E et al. Assessment of the carcinogenic potential of mitemcinal (GM-611): increased incidence of malignant lymphoma in a rat carcinogenicity study. 2008 Toxicol. Appl. Pharmacol. pmid:18355581
Dakhel Y and Jamali F Erythromycin potentiates PR interval prolonging effect of verapamil in the rat: a pharmacodynamic drug interaction. 2006 Toxicol. Appl. Pharmacol. pmid:16466760
Sadrieh N and Thomas PE Characterization of rat cytochrome P450 isozymes involved in the covalent binding of cyclosporin A to microsomal proteins. 1994 Toxicol. Appl. Pharmacol. pmid:8048065
Kalsotra A et al. Expression and characterization of human cytochrome P450 4F11: Putative role in the metabolism of therapeutic drugs and eicosanoids. 2004 Toxicol. Appl. Pharmacol. pmid:15364545
Gaeta GB et al. Characterization of the effects of erythromycin estolate and erythromycin base on the excretory function of the isolated rat liver. 1985 Toxicol. Appl. Pharmacol. pmid:2992120
Hayashi S et al. Characterization of multinuclear hepatocytes induced in rats by mitemcinal (GM-611), an erythromycin derivative. 2008 Toxicol Pathol pmid:18776165
Abdel-Hameid NA Protective role of dimethyl diphenyl bicarboxylate (DDB) against erythromycin induced hepatotoxicity in male rats. 2007 Toxicol In Vitro pmid:17267170
Peyre L et al. High-content screening imaging and real-time cellular impedance monitoring for the assessment of chemical's bio-activation with regards hepatotoxicity. 2015 Toxicol In Vitro pmid:26239606
Giuliano MW and Miller SJ Site-Selective Reactions with Peptide-Based Catalysts. 2016 Top Curr Chem pmid:26307403
Hara T et al. Successful treatment of severe reflux esophagitis with erythromycin in a patient with progressive systemic sclerosis and proximal gastrectomy. 2006 Tokai J. Exp. Clin. Med. pmid:21302226
Partiarca PA et al. Outbreaks of pertussis in the United States: the Wisconsin experience. 1988 Tokai J. Exp. Clin. Med. pmid:3273611
Onodera T et al. Effect of fluid and antibiotic administration on experimental fecal peritonitis. 1968 Tohoku J. Exp. Med. pmid:5715596
Kanemitsu K et al. Efficacy of amikacin combinations for nocardiosis. 2003 Tohoku J. Exp. Med. pmid:14649737
Ramos CJ and Antonetti DA The role of small GTPases and EPAC-Rap signaling in the regulation of the blood-brain and blood-retinal barriers. 2017 Tissue Barriers pmid:28632993
Høye S An extraordinary tale of an ordinary case. 2015 Tidsskr. Nor. Laegeforen. pmid:26130550
Loose LM et al. Adolescent with respiratory impairments and short-lived fever. 2015 Tidsskr. Nor. Laegeforen. pmid:26130549
Brauteset LV et al. [Invasive pneumoccal disease in children in Oslo 1998-2004]. 2008 Tidsskr. Nor. Laegeforen. pmid:18552897
Afset JE and Maeland JA [Erythromycin and ciprofloxacin resistant Campylobacter jejuni]. 2001 Tidsskr. Nor. Laegeforen. pmid:11571989
Waterworth PM et al. A critical investigation into the antibiotic sterilization of heart valve homografts. 1974 Thorax pmid:4368321
White RJ Why use erythromycin? 1994 Thorax pmid:7974308
Oaklay CM Prevention of infective endocarditis. 1979 Thorax pmid:542909
Ellis ME and Dunbar EM In vivo response of acute Q fever to erythromycin. 1982 Thorax pmid:7164010
Domingo C et al. Radiographic appearance of nosocomial legionnaires' disease after erythromycin treatment. 1991 Thorax pmid:1948796
Venkatesan P et al. A hospital study of community acquired pneumonia in the elderly. 1990 Thorax pmid:2356552
Fujii T et al. Long term effect of erythromycin therapy in patients with chronic Pseudomonas aeruginosa infection. 1995 Thorax pmid:8553295
Tsang KW et al. Clinical profiles of Chinese patients with diffuse panbronchiolitis. 1998 Thorax pmid:9741370
Guest PJ et al. Pulmonary Mycobacterium kansasii infection successfully treated with a regimen containing erythromycin. 1988 Thorax pmid:3420563
Brugiere O et al. Diffuse panbronchiolitis in an Asian immigrant. 1996 Thorax pmid:8977613
Koyama H and Geddes DM Erythromycin and diffuse panbronchiolitis. 1997 Thorax pmid:9404381
McCulloch AJ et al. Severe steroid responsive pneumonitis associated with pyoderma gangrenosum and ulcerative colitis. 1985 Thorax pmid:4023983

Table of Content